Diseases /
Malignant Testicular Neoplasm
Back to Diseases List
Associated Genetic Biomarkers
Overview
Malignant testicular neoplasms most frequently harbor alterations in KRAS, CDKN1B, ETV6, CCND2, and RAD52 [2].
CDKN1B Amplification, CCND2 Amplification, ETV6 Amplification, RAD52 Amplification, and KRAS Amplification are the most common alterations in malignant testicular neoplasm [2].
Clinical Trials
Significant Genes in Malignant Testicular Neoplasm
Disease Details
References
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.
3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.